Defluoro O-Methyl Dolutegravir Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Defluoro O-Methyl Dolutegravir is an intermediate in the synthesis of Defluoro Dolutegravir (D228715) which is an impurity of Dolutegravir (D528800), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.

Defluoro O-Methyl Dolutegravir Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Defluoro O-Methyl Dolutegravir Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Beijing Comparison Pharmaceutical Technology Co., Ltd	010-010-52878169 15801002657	sales@bjcomparison.com	China	4717	58
Wuxi Helen Biotechnology Co., Ltd.,	0510-85629785 18013409632	sales@reading-chemicals.com	China	14081	58

---

• Defluoro O-Methyl Dolutegravir
• 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(4-fluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-, (4R,12aS)-
• (4R,12aS)-N-(4-fluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6, 8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine9-carboxamide
• 2244245-33-6